WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$3.94B
1-Year Return
29.08%
This Quarter Return
-1.82%
1 Year Return
+29.08%
3 Year Return
+75.24%
5 Year Return
+223.81%
10 Year Return
+334.33%
AUM
$2.15B
AUM Growth
-$488M
(-19%)
Cap. Flow
-$444M
Cap. Flow
% of AUM
-20.68%
Top 10 Holdings %
Top 10 Hldgs %
14.69%
Holding
656
New
157
Increased
135
Reduced
136
Closed
160
Top Buys
| 1 |
VICI Properties
VICI
|
+$48.9M |
| 2 |
Canadian National Railway
CNI
|
+$28M |
| 3 |
Ventas
VTR
|
+$25.9M |
| 4 |
Microsoft
MSFT
|
+$23.3M |
| 5 |
COPT Defense Properties
CDP
|
+$23.2M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$575M |
| 2 |
Johnson & Johnson
JNJ
|
+$30.3M |
| 3 |
Sun Communities
SUI
|
+$26.7M |
| 4 |
Apple
AAPL
|
+$26.3M |
| 5 |
Prologis
PLD
|
+$26.1M |
Sector Composition
| 1 | Real Estate | 19.15% |
| 2 | Consumer Discretionary | 12.66% |
| 3 | Technology | 9.91% |
| 4 | Industrials | 9.91% |
| 5 | Utilities | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Blackstone
BX
$135B
| $320K | 0.01% |
10,000
-55,000
| -85% | -$1.76M |
|
|
PTLA
402
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $317K | 0.01% |
9,700
-300
| -3% | -$9.8K |
|
|
AKAO
403
DELISTED
Achaogen, Inc.
AKAO
| $313K | 0.01% |
24,180
-10,820
| -31% | -$140K |
|
|
BEL
404
DELISTED
Belmond Ltd.
BEL
| $312K | 0.01% |
+28,000
| New | +$312K |
|
405
AtriCure
ATRC
$1.79B
| $308K | 0.01% |
15,000
-5,000
| -25% | -$103K |
|
406
Apollo Global Management
APO
$76.9B
| $296K | 0.01% |
+10,000
| New | +$296K |
|
|
NSTG
407
DELISTED
NanoString Technologies, Inc.
NSTG
| $282K | 0.01% |
37,500
+2,500
| +7% | +$18.8K |
|
408
MGM Resorts International
MGM
$9.8B
| $280K | 0.01% |
8,000
-66,000
| -89% | -$2.31M |
|
|
OBSV
409
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $270K | 0.01% |
+20,000
| New | +$270K |
|
|
EPZM
410
DELISTED
Epizyme, Inc
EPZM
| $266K | 0.01% |
+15,000
| New | +$266K |
|
|
IMDZ
411
DELISTED
Immune Design Corp.
IMDZ
| $264K | 0.01% |
80,000
-89,034
| -53% | -$294K |
|
412
Ultragenyx Pharmaceutical
RARE
$3.04B
| $255K | 0.01% |
+5,000
| New | +$255K |
|
|
KERX
413
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $254K | 0.01% |
62,000
-2,000
| -3% | -$8.19K |
|
414
Cytokinetics
CYTK
$6.16B
| $252K | 0.01% |
35,000
-5,000
| -13% | -$36K |
|
|
AGEN
415
Agenus
AGEN
$136M
| $236K | 0.01% |
2,548
-2,038
| -44% | -$189K |
|
|
LOXO
416
DELISTED
Loxo Oncology, Inc
LOXO
| $231K | 0.01% |
2,000
-17,000
| -89% | -$1.96M |
|
|
INSY
417
DELISTED
Insys Therapeutics, Inc.
INSY
| $222K | 0.01% |
36,700
+2,200
| +6% | +$13.3K |
|
418
SPDR S&P MidCap 400 ETF Trust
MDY
$23.9B
| $217K | 0.01% |
+634
| New | +$217K |
|
419
Health Care Select Sector SPDR Fund
XLV
$34.4B
| $216K | 0.01% |
+2,657
| New | +$216K |
|
420
Carlyle Group
CG
$23.2B
| $214K | 0.01% |
+10,000
| New | +$214K |
|
421
KKR & Co
KKR
$124B
| $203K | 0.01% |
+10,000
| New | +$203K |
|
422
InflaRx
IFRX
$104M
| $202K | 0.01% |
+7,000
| New | +$202K |
|
|
ANW
423
DELISTED
Aegean Marine Petroleum Network
ANW
| $201K | 0.01% |
+89,408
| New | +$201K |
|
424
Sangamo Therapeutics
SGMO
$157M
| $190K | 0.01% |
10,000
-20,000
| -67% | -$380K |
|
425
Bilibili
BILI
$9.96B
| $165K | 0.01% |
+15,000
| New | +$165K |
|